Summary of Safety and Clinical Performance (SSCP)
A free guide to understanding and producing SSCPs for compliance with the MDR
- 4 minutes read
What is a Summary of Safety and Clinical Performance (SSCP)?
A SSCP is a document that must be produced by manufacturers of all Class III and implantable devices (other than custom-made or investigational devices) under the Medical Device Regulation (MDR). The Summary of Safety and Clinical Performance is an expression of one of the key aims of the MDR - to improve public access to the clinical data that underpins the safety and performance of medical devices.
A well-written SSCP will provide information that will be relevant to healthcare professionals as well as the general public. It will therefore need to be written in two sections, with appropriate choice of language to suit a professional and lay audience respectively.
A SSCP is not a replacement for the Instructions For Use (IFU) or implant cards that are associated with a device. Nor is it intended to give general advice on the management of medical conditions. It should contain device-specific information with a focus on relevant safety and clinical data.
What are the specific requirements for the Summary of Safety and Clinical Performance (SSCP)?
The SSCP must be objective, including summaries of both favourable and unfavourable data, as appropriate. It should draw entirely upon information contained in the technical documentation relating to the device, and should be updated when PMS, PMCF, Risk Management or Clinical Evaluation processes change such that the information in the SSCP becomes outdated.
The SSCP must be made available in English as well as the dominant language in all EU territories where the device is intended to be sold. The manufacturer is responsible for ensuring the accuracy of any translations.
The SSCP, at a minimum, should include the following sections:
- General device and manufacturer details (including UDI details)
- Intended purpose of device
- Indications, contraindications and target population
- Detailed description of device, including a description of any components such as medicinal products and any previous versions or variants of the device. Should include reference to alternatives to using the device.
- Details of residual risks, warnings and precautions
- A summary of the Clinical Evaluation of the device, in language that is appropriate to the reader, outlining evidence-based conclusions regarding the safety and performance of the device
- A description of necessary training and qualifications
- Harmonised standards applied
- Revision history
Each language version of the SSCP should be a separate document, headed with a clear indication of the language used throughout. SSCPs will be reviewed for quality of content as well as choice of language and its suitability for the intended audiences.
Where can I find additional help in producing a Summary of Safety and Clinical Performance?
A SSCP is a core document in the regulatory portfolio of Class III and implantable products. It should be produced after consulting recognised guidelines and, preferably, after taking professional advice regarding content and writing style.
The Medical Device Coordination Group has produced a range of guideline documents which have been updated to reflect changes introduced by the MDR. MDCG 2019-9 - Summary of safety and clinical performance - a guide for manufacturers and notified bodies is an authoritative source of guidance that also provides a detailed template for structuring the SSCP.
Alongside structure, it is vital to ensure access to the level of medical writing expertise necessary to meet the challenge of writing for both technical and lay readers. Medical writing requirements may necessitate the involvement of dedicated professionals with the necessary levels of medical communication experience.